Skip to main content

Table 4 Antihistamine Utilization (Entire Observation Period) - Stratified by Provider Type

From: Effects of variations in access to care for children with atopic dermatitis

  Dermatologist A/I Pediatrics Other
Number of patients, n (%) 58,758 (12.3) 29,994 (6.3) 169,455 (35.5) 219,277 (45.8)
Systemic antihistamine use, n (%) 17,195 (29.3) 13,146 (43.8) 63,904 (37.7) 128,083 (58.4)
 Non-sedating antihistamine onlya, n (%) 4651 (27.0) 6556 (49.9) 32,424 (50.7) 63,284 (49.4)
  ≥1 sedating antihistamine, n (%) 12,544 (72.9) 6590 (50.1) 31,480 (49.3) 64,799 (50.6)
Medicaid-insured patients, n (%) 8160 7144 60,268 165,076
Systemic antihistamine use, n (%) 5933 (72.7) 6123 (85.7) 42,416 (70.4) 116,039 (70.3)
 Non-sedating antihistamine onlya, n (%) 2467 (41.6) 3897 (63.6) 25,852 (60.9) 59,976 (51.7)
  ≥1 sedating antihistamine, n (%) 3466 (58.4) 2226 (36.4) 16,564 (39,1) 56,063 (48.3)
Commercially insured patients, n (%) 50,598 22,850 109,187 54,201
Systemic antihistamine use, n (%) 11,262 (22.3) 7023 (30.7) 21,488 (19.7) 12,044 (22.2)
 Non-sedating antihistamine onlya, n (%) 2184 (19.4) 2659 (37.9) 6572 (30.6) 3308 (27.5)
  ≥1 sedating antihistamine, n (%) 9078 (80.6) 4364 (62.1) 14,916 (69.4) 8736 (72.5)
  1. A/I Allergist/Immunologist, Rx Prescription
  2. aNon-sedating antihistamines do not require Rx, but some Medicaid plans will cover the cost with Rx